[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533926":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":32,"collaborators":7,"id":35,"slug":7,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":7,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":7,"maxAge":42,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Mohammed Gamil, Professor","STUDY_DIRECTOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Marina Farah Fawzy Gad, Master","CONTACT","01069928577","m_marina70@yahoo.com",[19],{"facility":5,"status":7,"city":20,"state":7,"zip":7,"country":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Asyut","Egypt",{"type":23,"coordinates":24},"Point",[25,26],31.18368,27.18096,{"lat":26,"lon":25},[29],{"name":30,"role":31,"phone":7,"phoneExt":7,"email":7},"marina farah fawzy, master","PRINCIPAL_INVESTIGATOR",{"type":31,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"marina farah fawzy gad","Pediatric resident","100533926",false,"NCT06232174","Value of Transcutaneous Bilirubin Devices","Study of the Value of Transcutaneous Bilirubin Devices in Jaundiced Newborns at Assiut University Children's Hospital","Inclusion Criteria:\n\n* They were born between 35 and 42 weeks of gestation, had a birth weight of more than 2 kg, and were aged between 0 days and 28 days\n\nExclusion Criteria:\n\n* Exclusion criteria are severely ill neonates, neonates with a lethal congenital malformation, and or had skin disease, had received phototherapy before, and received exchange transfusion.","ALL","28 Days",{"count":44,"type":45},80,"ESTIMATED","25 Days","OBSERVATIONAL","The goal of this observational study is to compare the value of transcutaneous bilirubin devices versus serum bilirubin in jaundiced neonates",[50],"Jaundice",[52],"Neonatal jaundice","NOT_YET_RECRUITING","2024-07-29",{"date":56,"type":57},"2024-07-30","ACTUAL",{"date":59,"type":45},"2024-08",{"date":61,"type":45},"2025-03",{"name":5,"class":6},1]